跳至主要内容
临床试验/CTRI/2025/09/095106
CTRI/2025/09/095106尚未招募3 期

Clinical research study to evaluate the efficacy of a stannous fluoride toothpaste on established dental plaque and gingivitis in adults

Colgate-Palmolive Company1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年9月29日最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
100
试验地点
1
主要终点
Gingivitis (Loe and Silness Index)

研究概览

简要总结

The objective of this clinical research study is to evaluate the efficacy of a specialized toothpaste on established dental plaque and gingivitis in adults. This is a phase III, single center, randomized, parallel and double blinded study conducted on about 100 subjects in the age group between 18 to 70 years.

The subjects will be exposed to either of 2 different test products for a period of 6 months with a treatment regimen of whole mouth brushing twice daily for 2 minutes.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Potential subjects must meet ALL of the following criteria: Males and females, between 18-70 years of age; Informed Consent Form signed and availability for the duration of the study; Good general health (absence of any condition that, in the opinion of the Principal Investigator, might constitute a risk to the subject while participating in the study.
  • Examples include heart problems, valve/hip replacements, etc); Willingness to provide information related to their medical history; Minimum of 15 uncrowned permanent natural teeth (excluding third molars); Initial mean gingivitis index of at least 1 as determined by the use of the Loe and Silness Gingival Index and mean Plaque Index score of at least 1.5 determined by the Turesky modification of the Quigley-Hein Plaque Index; Availability for the duration of the study.

排除标准

  • 未提供

结局指标

主要结局

Gingivitis (Loe and Silness Index)

时间窗: Baseline, 3 months and 6 months

次要结局

  • Plaque (Turesky modification of the Quigley-Hein Plaque Index)(Baseline, 3 months and 6 months)

研究者

申办方类型
Other [FMCG - Global]
责任方
Principal Investigator
主要研究者

Dr Ashish Kakar

GLOBAL HEALTH RESERCH GROUP

研究点 (1)

Loading locations...

相似试验